These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1328433)

  • 1. Combination treatment with ribavirin and interferon for coxsackievirus B3 replication.
    Okada I; Matsumori A; Matoba Y; Tominaga M; Yamada T; Kawai C
    J Lab Clin Med; 1992 Oct; 120(4):569-73. PubMed ID: 1328433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of combined treatment of Shuanghuanglian and recombinant interferon alpha 2a on coxsackievirus B3 replication in vitro].
    Lu HT; Yang JC; Yuan ZC; Sheng WH; Yan WH
    Zhongguo Zhong Yao Za Zhi; 2000 Nov; 25(11):682-4. PubMed ID: 12525074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xiao chai hu tang inhibits CVB1 virus infection of CCFS-1 cells through the induction of Type I interferon expression.
    Cheng PW; Ng LT; Lin CC
    Int Immunopharmacol; 2006 Jun; 6(6):1003-12. PubMed ID: 16644487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of finding synergic in vitro drug-drug interactions between interferon-alpha and ribavirin for the treatment of hepatitis C virus.
    Buckwold VE
    J Antimicrob Chemother; 2004 Mar; 53(3):413-4. PubMed ID: 14963071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupleurum kaoi inhibits Coxsackie B virus type 1 infection of CCFS-1 cells by induction of type I interferons expression.
    Cheng PW; Chiang LC; Yen MH; Lin CC
    Food Chem Toxicol; 2007 Jan; 45(1):24-31. PubMed ID: 17052829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of verapamil on acute coxsackievirus B3 murine myocarditis.
    Xu Y; Yang YZ; Chen HZ; Jin PY; Guo Q; Zhao WZ; Yang JH; Cai QX; Zhou YC
    Chin Med J (Engl); 1992 Oct; 105(10):818-21. PubMed ID: 1337875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cultured human myocardial fibroblasts of pediatric origin: natural human interferon-alpha is more effective than recombinant interferon-alpha 2a in carrier-state coxsackievirus B3 replication.
    Heim A; Brehm C; Stille-Siegener M; Müller G; Hake S; Kandolf R; Figulla HR
    J Mol Cell Cardiol; 1995 Oct; 27(10):2199-208. PubMed ID: 8576936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coxsackievirus B3 replication and persistence in intestinal cells from mice infected orally and in the human CaCo-2 cell line.
    Harrath R; Bourlet T; Delézay O; Douche-Aourik F; Omar S; Aouni M; Pozzetto B
    J Med Virol; 2004 Oct; 74(2):283-90. PubMed ID: 15332278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of coxsackievirus B3 carrier state infection of cultured human myocardial fibroblasts by ribavirin and human natural interferon-alpha.
    Heim A; Grumbach I; Pring-Akerblom P; Stille-Siegener M; Müller G; Kandolf R; Figulla HR
    Antiviral Res; 1997 May; 34(3):101-11. PubMed ID: 9191017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cardioprotective effect of Wusen Erlian Granules through the inhibition of Coxsackievirus B3 replication.
    Cao Y; Hao L; Han CH; Zhang PY
    Cell Biochem Biophys; 2015 Mar; 71(2):1135-9. PubMed ID: 25388835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleomycin differentially inhibits picornavirus, herpesvirus and poxvirus replication in a human carcinoma cell line.
    Nørskov-Lauritsen N; Ebbesen P
    In Vivo; 1993; 7(6A):481-5. PubMed ID: 7514894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antiviral activities of acyclovir and recombinant human leukocyte (alpha) interferon on feline herpesvirus replication.
    Weiss RC
    Am J Vet Res; 1989 Oct; 50(10):1672-7. PubMed ID: 2552872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of soluble coxsackievirus-adenovirus receptor and anti-coxsackievirus siRNAs exerts synergistic antiviral activity against coxsackievirus B3.
    Werk D; Pinkert S; Heim A; Zeichhardt H; Grunert HP; Poller W; Erdmann VA; Fechner H; Kurreck J
    Antiviral Res; 2009 Sep; 83(3):298-306. PubMed ID: 19591879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent inhibition of respiratory syncytial virus by combination treatment with 2-5A antisense and ribavirin.
    Xu Z; Kuang M; Okicki JR; Cramer H; Chaudhary N
    Antiviral Res; 2004 Mar; 61(3):195-206. PubMed ID: 15168801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of a hepatitis C virus NS3-NS4A protease inhibitor and alpha interferon synergistically inhibits viral RNA replication and facilitates viral RNA clearance in replicon cells.
    Lin K; Kwong AD; Lin C
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4784-92. PubMed ID: 15561857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yakammaoto inhibited human coxsackievirus B4 (CVB4)-induced airway and renal tubular injuries by preventing viral attachment, internalization, and replication.
    Yen MH; Lee JJ; Yeh CF; Wang KC; Chiang YW; Chiang LC; Chang JS
    J Ethnopharmacol; 2014 Feb; 151(3):1056-1063. PubMed ID: 24361333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication.
    Wilsky S; Sobotta K; Wiesener N; Pilas J; Althof N; Munder T; Wutzler P; Henke A
    Arch Virol; 2012 Feb; 157(2):259-69. PubMed ID: 22075919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3.
    Martin U; Jarasch N; Nestler M; Rassmann A; Munder T; Seitz S; Zell R; Wutzler P; Henke A
    Apoptosis; 2007 Mar; 12(3):525-33. PubMed ID: 17211569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of LNA-modified siRNAs against the highly structured 5' UTR of coxsackievirus B3.
    Dutkiewicz M; Grunert HP; Zeichhardt H; Lena SW; Wengel J; Kurreck J
    FEBS Lett; 2008 Sep; 582(20):3061-6. PubMed ID: 18691577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.